|
TNX-103 Clinical Trials
2 actively recruiting trials across 2 locations
Alexander City, Alabama1 trial
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Tenax Investigational Site
Phase 3
Tucson, Arizona1 trial
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
Tenax Investigational Site
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.